Elox-SOLOpharm
Indications for use
Initial therapy and short-term symptomatic treatment in:
- osteoarthritis (arthrosis, degenerative joint diseases);
- rheumatoid arthritis, ankylosing spondylitis;
- other inflammatory and degenerative diseases of the musculoskeletal system, such as arthropathies, dorsopathies (for example, sciatica, low back pain, shoulder periarthritis, and others), associated with pain.
Indications for use
Initial therapy and short-term symptomatic treatment in:
- osteoarthritis (arthrosis, degenerative joint diseases);
- rheumatoid arthritis, ankylosing spondylitis;
- other inflammatory and degenerative diseases of the musculoskeletal system, such as arthropathies, dorsopathies (for example, sciatica, low back pain, shoulder periarthritis, and others), associated with pain.
Therapeutic class:
Non-steroidal anti-inflammatory drug (NSAID)
INN
Meloxicam
Blow-Fill-Seal
Market authorization in the following countries
Azerbaijan
Kyrgyzstan